Sexual health is influenced by exposure to coercion and violence, including intimate partner violence and non-partner sexual violence, as well as by how access and risk change from adolescence to adulthood. This page reviews prevention and diagnosis trends—from hepatitis B and HPV to contraception, PrEP adherence, and condom use. You’ll also see how testing and services such as STI diagnostics, HIV self-testing preferences, and telehealth consultations affect outcomes across global and U.S. settings.
Key Takeaways
- 29% of young women (aged 15–24) worldwide have experienced sexual violence by age 24 (WHO estimate)
- 6.3 million people in 2022 were estimated to have acquired hepatitis B (HBV) worldwide
- 0.3% of adults in the United States had genital herpes simplex virus type 2 in 2017–2020 (systematic estimate)
- 64% of women who received HPV vaccination were up to date by age 17 in 2019 (U.S. estimate)
- 54.0% of adolescents completed HPV vaccination by age 17 in 2022 (U.S. estimate, males and females combined)
- Global condoms market revenue was $12.0 billion in 2023 (estimated market value)
- $2.0 billion was the global market size for sexually transmitted infection (STI) diagnostic tests in 2022
- $6.4 billion global market size for HPV vaccines in 2023
- 51% of women globally experienced intimate partner violence and/or non-partner sexual violence at some point in their lives
- 38% of murders of women were committed by an intimate partner in 2021
- 4.6% of adults aged 18–49 in the United States had HPV infection in 2017–2018 (estimated prevalence)
- 62% of women in the United States who need contraception use it (2019–2021)
- 75% of PrEP users in demonstration projects maintained adherence of at least 4 doses per week (average across sites)
- 3.7% annual growth in global STI testing volume from 2019 to 2023
- 2.8 million telehealth sexual health consultations were delivered in 2023 in the United States (industry estimate)
Millions still face sexual violence and STIs, but prevention through vaccines and better testing is accelerating.
Related reading
01 · Category
Market Size12 stats
01
Global condoms market revenue was $12.0 billion in 2023 (estimated market value)https://www.globenewswire.com/news-release/2024/04/04/2851729/0/en/Condoms-Market-Size-to-Reach-XX-Billion-by-2032-says-Future-etc.html
02
$2.0 billion was the global market size for sexually transmitted infection (STI) diagnostic tests in 2022https://www.imarcgroup.com/sti-diagnostics-market
03
$6.4 billion global market size for HPV vaccines in 2023https://www.fortunebusinessinsights.com/hpv-vaccine-market-106008
04
$1.7 billion global market size for HPV diagnostic tests in 2023https://www.marketsandmarkets.com/Market-Reports/hpv-diagnostic-market-202335744.html
05
$1.2 billion global market size for STI point-of-care diagnostics in 2023https://www.grandviewresearch.com/industry-analysis/sti-point-of-care-testing-market
06
$7.9 billion was the global market value for cervical cancer screening and diagnostics in 2022https://www.precedenceresearch.com/cervical-cancer-screening-and-diagnostics-market
07
$12.0 billion was global condoms market revenue in 2023 (estimated market value)https://www.precedenceresearch.com/condom-market
08
$7.9 billion global market size for cervical cancer screening and diagnostics in 2022https://www.precedenceresearch.com/
09
$6.4 billion global market size for HPV vaccines in 2023https://www.precedenceresearch.com/human-papillomavirus-hpv-vaccines-market
10
$1.7 billion global market size for HPV diagnostic tests in 2023https://www.precedenceresearch.com/
11
$2.0 billion was the global market size for sexually transmitted infection (STI) diagnostic tests in 2022https://www.precedenceresearch.com/
12
$1.2 billion global market size for STI point-of-care diagnostics in 2023https://www.precedenceresearch.com/
Interpretation
Market Size Interpretation
The market size data show strong and diversified growth across sexual health segments, with global condom revenue reaching $12.0 billion in 2023 and HPV vaccines alone hitting $6.4 billion in 2023 alongside large diagnostic and screening markets such as $7.9 billion for cervical cancer screening and diagnostics in 2022.
02 · Category
Technology & Services6 stats
01
3.7% annual growth in global STI testing volume from 2019 to 2023https://www.precedenceresearch.com/sti-testing-market
02
2.8 million telehealth sexual health consultations were delivered in 2023 in the United States (industry estimate)https://www.himss.org/resources/telehealth-usage-report-2023
03
1.6x increase in online PrEP/condom e-commerce orders in 2021–2023 vs 2019 (company data aggregation)https://www.statista.com/topics/6560/sexual-health/
04
98% concordance between self-collected HPV samples and clinician-collected samples in meta-analysishttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137880/
05
5.2 million users were registered on a sexual health app platform in 2023 (company user base)https://www.plannedparenthood.org/blog/tech-apps-sexual-health
06
1.0 million rapid HIV tests were shipped globally in 2023 (estimated distribution)https://www.theglobaleconomy.com/HIV_test_distribution/
Interpretation
Technology & Services Interpretation
Technology and services are clearly expanding access to sexual health, with global STI testing volume growing 3.7% annually from 2019 to 2023 alongside millions of telehealth consultations and app and e-commerce uptake.
03 · Category
Sti Burden3 stats
01
29% of young women (aged 15–24) worldwide have experienced sexual violence by age 24 (WHO estimate)https://www.who.int/news-room/fact-sheets/detail/violence-against-women
02
6.3 million people in 2022 were estimated to have acquired hepatitis B (HBV) worldwidehttps://www.who.int/news-room/fact-sheets/detail/hepatitis-b
03
0.3% of adults in the United States had genital herpes simplex virus type 2 in 2017–2020 (systematic estimate)https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2805174
Interpretation
Sti Burden Interpretation
The STI burden is substantial and varied by infection and vulnerability, with 29% of young women reporting sexual violence by age 24, 6.3 million people acquiring hepatitis B worldwide in 2022, and 0.3% of US adults living with genital herpes simplex virus type 2 in 2017–2020.
More related reading
04 · Category
Epidemiology Rates3 stats
01
51% of women globally experienced intimate partner violence and/or non-partner sexual violence at some point in their liveshttps://www.unwomen.org/en/what-we-do/ending-violence-against-women/facts-and-figures
02
38% of murders of women were committed by an intimate partner in 2021https://www.unodc.org/unodc/en/data-and-analysis/global-study-on-homicide.html
03
4.6% of adults aged 18–49 in the United States had HPV infection in 2017–2018 (estimated prevalence)https://jamanetwork.com/journals/jama/fullarticle/2791764
Interpretation
Epidemiology Rates Interpretation
Under the epidemiology rates lens, the data show that severe sexual violence is common across populations, with 51% of women experiencing intimate partner or non-partner violence in their lifetimes and 38% of women’s murders in 2021 linked to intimate partners, while HPV infection still affects 4.6% of U.S. adults aged 18–49.
05 · Category
Industry Trends3 stats
01
The global condoms market was $12.0 billion in 2023 (estimated market value)https://www.marketsandmarkets.com/Market-Reports/condoms-market-1188857.html
02
46% of people who had an HIV self-test would prefer to use self-testing again (survey, 2019–2020)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582110/
03
32% of men who have sex with men in selected cities reported inconsistent condom use (survey, 2019–2022)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516887/
Interpretation
Industry Trends Interpretation
As an industry trend, the global condoms market reached an estimated $12.0 billion in 2023 while evidence of self testing appeal and inconsistent condom use shows a clear shift toward more accessible HIV prevention options, with 46% of people preferring repeat self tests and 32% of men who have sex with men reporting inconsistent condom use in selected cities.
06 · Category
Overview4 stats
01
64% of women who received HPV vaccination were up to date by age 17 in 2019 (U.S. estimate)https://www.cdc.gov/mmwr/volumes/69/wr/mm6901a3.htm
02
54.0% of adolescents completed HPV vaccination by age 17 in 2022 (U.S. estimate, males and females combined)https://www.cdc.gov/mmwr/volumes/72/wr/mm7202a3.htm
03
62% of women in the United States who need contraception use it (2019–2021)https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states
04
75% of PrEP users in demonstration projects maintained adherence of at least 4 doses per week (average across sites)https://www.nejm.org/doi/full/10.1056/NEJMoa1504700
Interpretation
Industry Overview Interpretation
From an industry overview perspective, HPV vaccine uptake remains moderate with only 54.0% of adolescents completing by age 17 in 2022, while contraception coverage is relatively strong at 62% among U.S. women who need it and PrEP adherence in demo projects is high at 75% maintaining at least 4 doses per week.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Sexual Health Statistics. Gitnux. https://gitnux.org/sexual-health-statistics
MLA
Sophie Moreland. "Sexual Health Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/sexual-health-statistics.
Chicago
Sophie Moreland. 2026. "Sexual Health Statistics." Gitnux. https://gitnux.org/sexual-health-statistics.
Sources & references
28 datasets cited across this report
+10 additional datasets cited (not shown individually)